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Summary
We describe four new mutations in the JI-galactosidase gene. These are the first mutations causing infantile and
juvenile GM1-gangliosidosis to be described in American patients. Cell lines from two patients with juvenile
and from six patients with infantile GM1-gangliosidosis were analyzed. Northern blot analysis showed the acid
P-galactosidase message to be of normal size and quantity in two juvenile and four infantile cases and of normal
size but reduced quantity in two infantile cases. The mutations are distinct from the Japanese mutations. All
are point mutations leading to amino acid substitutions: Lyss-77 .Arg, Arg590>-His, and Glu632-'-Gly. The fourth
mutation, Arg208-*Cys, accounts for 10 of 16 possible alleles. Two infantile cases from Puerto Rico of Spanish
ancestry are homozygous for this mutation, suggesting that this allele may have come to South America and
North America via Puerto Rico. That these mutations cause clinical disease was confirmed by marked reduction
in catalytic activity of the mutant proteins in the Cos-1 cell expression system.
Introduction
Genetic deficiency of lysosomal P-galactosidase in hu-
mans causes both GM1-gangliosidosis, a progressive
neurological disorder, and Morquio disease type B
(Morquio B), the latter manifesting as generalized skele-
tal dysplasia with connective tissue involvement
(O'Brien 1989; Wray and Boustany 1989). GM1-gang-
liosidosis has three clinical phenotypes: (1) an infantile
variant: onset is at birth to age 2 mo, with hypotonia,
coarse features, organomegaly, and cherry red spots
and with death by 1 to 2 years of age; (2) a juvenile
variant: onset is between 1 and 2 years of age, with a lag
in motor and cognitive development and lack of dys-
morphic features (survival can be until the teen years);
and (3) an adult variant: onset is late, with a progressive
extrapyramidal disorder due to local deposition of
GM1-gangliosidosis in the caudate nucleus. Oshima
(1988) and Morreau et al. (1989) published the normal
cDNA sequence for acid P-galactosidase, allowing the
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mutational analysis of the 0-galactosidase gene in pa-
tients with GM,-gangliosidosis and Morquio B (Nishi-
moto et al. 1991; Oshima et al. 1991). We have exam-
ined the acid P-galactosidase gene in eight North
American and South American patients and have iden-
tified four new mutations.
Patients, Material, and Methods
Patients
Eight patients from North American and South
American families were included in the study. Three of
the families were of Hispanic descent. The clinical find-
ings are summarized in table 1.
Commercial Materials
Bethesda Research Laboratories (Gaithersburg,
MD), Boehringer-Mannheim (Indianapolis), New En-
gland Biolabs (Beverly, MA), Pharmacia LKB Biotech-
nology (Piscataway, NJ), Promega (Madison, WI),
Fisher-Scientific (Fair Lawn, NJ), Sigma Chemical (St.
Louis), and United States Biochemical (Cleveland) were
the main sources for standard enzymes, reagents, and
other supplies. Radioisotopes were purchased from
DuPont New England Nuclear (Boston).
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Table I
Phenotype/Genotype Summary of North American and South American Mutations
AT DIAGNOSIS
AGE mRNA
TYPE AT Large Bony (size,
CASE (sex) ORIGIN ONSET Age CRS' Liver Changes HCb amount) ALLELES
1 ... Juvenile (F) English- 12 mo 21/2 years -d- _ + + R59OH/R208C
German (U/S)
2 ... Infantile (F) English 4 mo 20 mo + - - N +, + K577R/R208C
(W/S)
3 ... Infantile (M) Eastern ? 2/2 years - + N +, + R208C/? (S/?)
European-
English
4 ...... Infantile (F) Puerto 10 mo 2 years - - + N 4 d R208C/R208C
Rican (S/S)
5 ...... Infantile (F) Mexican 6 mo 11 mo + + s d + + K577R/R208C
(W/S)
6 ...... Juvenile (F) English- 41/2 years 8 years N +,+ E632G/R208C
Scottish (Z/S)
7 ...... Infantile (M) Puerto 6 mo 1 year ? + + N +, d R208C/R208C
Rican (S/S)
8 ...... Infantile (F) English 5 mo 13 mo - -_ 4d + + R208C/? (S/?)
a Cherry red spot.
b Head circumference.
c N = normal.
d Diminished.
Cell Culture
Skin fibroblasts were grown in Dulbecco's modified
Eagle minimum essential medium supplemented with
10% FCS at 37°C in 5% CO2 atmosphere. Normal con-
trol cell lines and disease control cell lines were selected
from the stock in our laboratory (disease controls in-
cluded infantile GM2-gangliosidosis and late-infantile
and juvenile neuronal ceroid lipofuscinosis).
RNA Preparation and Northern Analysis
Total RNA was isolated from 20 100-mm Petri
dishes by the single-step method using phenol saturated
with water, sodium acetate, and guanidium isothio-
cyanate. Thirty micrograms of total RNA were electro-
phoresed in a 1% agarose, 0.6 M formaldehyde gel and
were transferred to a nylon membrane (Biotrans; ICN
Biomedicals, Costa Mesa, CA). The full-length normal
human 0-galactosidase cDNA probe and the 1.1-kb f-
actin probe were labeled by nick-translation with [a-
32P]dCTP. Hybridization and subsequent washings
were done according to instructions supplied by the
manufacturer. The P-galactosidase cDNA probe was
stripped from the filter by boiling for 5 min in 100 mM
Tris-HCI pH 7.5, 1 mM EDTA, 1% SDS. The same
filter was reprobed by using the labeled P-actin cDNA.
Reverse Transcription and PCR Amplification
Five micrograms of total RNA were reverse tran-
scribed by using 0.5 ig oligo dT/jg RNA and 45 units
of AMV reverse transcriptase. The resultant first-
strand cDNA was amplified in two segments, divided at
the internal EcoRI site with two pairs of primers. The 5'
and 3' segments were 800 bp and 1,500 bp, respectively.
Thirty cycles of amplification were carried out in 100 gl
of the reaction mixture with 2.5 units of Taq polymer-
ase (Perkin Elmer Cetus, Norwalk, CT). Denaturing
temperature was 94°C for 1 min, annealing tempera-
ture was 60°C for 2 min, and extension temperature
was 72°C for 3 min.
Subcloning and Sequence Analysis
The amplified segments were digested, separated by
gel electrophoresis, and directly extracted from the gel
bands, using phenol and phenol-chloroform prior to
subcloning into pGEM-3zf(-) vector (Promega, Madi-
son, WI). At least four clones per fragment per patient
were analyzed. Double-stranded sequencing was
Boustany et al.882
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N 1 2 3 4 5 6 7 8 N
Figure I Northern blot analysis. Thirty micrograms of total
RNA sample isolated from fibroblasts were electrophoresed on a
denaturing formaldehyde agarose gel. Top, Probe was the full-length
human ,-galactosidase cDNA. Bottom, Blot was then stripped and
reprobed with the P-actin cDNA to allow for comparative quantita-
tion. The numbers below the diagram indicate case numbers as in
table 1. Lanes N, Normal controls. The arrow indicates the position
of the normal f-galactosidase mRNA at 2.4 kb. The message was of
normal size in all cases but was diminished in quantity in two infantile
patients (cases 4 and 7). All other patients showed mRNA of normal
size and quantity.
carried out with the Sequenase version 2.0 kit (United
States Biochemicals, Cleveland), 35S-labeled ATP (Du-
Pont New England Nuclear, Boston), and SP6, T-7, and
M-13 universal primers.
Genotype Determination with Allele-specific
Oligonucleotides
Genomic DNA was isolated from four 100-mm Petri
dishes according to standard methods. Approximately
500 ng of genomic DNA were used as template for PCR
amplification of target exons, with appropriate primers.
Thirty cycles of amplification were carried out, with a
denaturing temperature of 94°C for 1 min, an annealing
temperature of 50°C for 2 min, and an extension tem-
perature of 72°C for 3 min. Extension during the last
cycle was carried out for 10 min. The amplified seg-
ments were purified by phenol-chloroform extraction
and were precipitated in ethanol. Fifteen nanograms of
the PCR products were dot blotted onto Gene Screen
Plus membrane, using a BRL Hybri-Dot manifold (Be-
thesda Research Labs, Gaithersburg, MD). The mem-
brane was baked for 2 h at 80'C and hybridized at
450C for 2 h in 6 X SSC, 5 X Denhardt's solution, 10
mM sodium phosphate, 0.5% SDS, and 100 ig heat-
denatured herring sperm DNA/ml. Hybridization was
at 450C overnight in the same solution with 2 X 106
cpm appropriate oligonucleotide probe labeled at the 5'
terminus with [y-32P]ATP and T4 polynucleotide ki-
nase. The membrane was washed at room temperature
in 2 X SSC for 10 min twice, then at 50C lower than the
melting temperature for the oligonucleotide in 2 X SSC,
0.1% SDS for 15 min, and was finally autoradiographed
after exposure at -70'C.
Direct Sequencing of Amplified Target Exons from
Genomic DNA
Amplified exons were gel purified, and 0.1 pmol of
purified PCR product was denatured by heating 2 min
at 950C, then snap cooled in a dry ice/ethanol bath for
1 min and annealed to 0.5 pmol of primer for 30 min.
Double-stranded sequencing was carried out as previ-
ously described, with Sequenase and 35S-labeled ATP.
Expression ofCatalytic Activity in the Cos- I Cell System
Transformed African green monkey kidney cells
(Cos-1) were purchased from the American Type Cul-
ture Collection (Rockville, MD). cDNAs, each bearing
only one of the four identified mutations, were con-
structed from the normal cDNA and appropriate frag-
ments of the mutant cDNA in the pGEM-3zf(-) vec-
tor. The cDNA inserts containing the entire coding
region (normal P-galactosidase or one of four mutant
0-galactosidase cDNAs) were excised from the plasmid
by XbaI/SacI double digestion and subcloned into the
pSVL eukaryotic expression vector (Pharmacia LKB
Biotechnology, Piscataway, NJ). Transfection of the
Cos-1 cells was achieved by utilizing liposomes (Lipo-
fectin Reagent, BRL). The period of transfection was 5
h with 0.5 gg of plasmid DNA and 50 p1 of the Lipofec-
tin Reagent/35-mm dish. At 72 h after transfection the
cells were harvested for enzyme assay.
Enzyme Assay
Acid 0-galactosidase activity was determined from
homogenates of cultured fibroblasts or transfected
Cos-1 cells by using 4-methylumbelliferyl P-D-galacto-
side (Koch-Light Labs, Colnbrook Bucks, U.K.) (Suzuki
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Figure 2 Mutations in patients with GM1-gangliosidosis. Loca-
tion of mutations is indicated by arrows. The coding strand is the tem-
plate for sequencing in all cases. a, Infantile: KS77R (W) = Lys577_Arg
(1733AAG-'AGG); R208C (S) = Arg2M-.Cys (6CGC-TGC). b,
































































































Mutations in Acid P-Galactosidase
procedure using the Bio-Rad Protein Assay kit (Bio-
Rad Labs, Richmond, CA).
Results
Biochemistry and Northern Blot Analysis
The diagnosis of GM1-gangliosidosis was confirmed
in all patients by deficient activities of acid 3-galactosi-
dase in cultured fibroblasts and peripheral leukocytes.
All the infantile cases had enzyme activities less than 5%
that of normal controls, as did one of the juvenile cases.
The second juvenile case had an acid f-galactosidase
activity 10% of normal. All cases had normal sialidase
activities in cultured fibroblasts (results not shown).
Northern blot analysis indicated that both juvenile
cases and four infantile cases had an acid 0-galactosi-
dase mRNA of normal size and quantity (fig. 1). It was
of normal size but reduced in quantity in two infantile
cases (cases 4 and 7). A 1.1-kb m-actin cDNA was used
as the control transcript to equalize for RNA content.
Sequence Analysis ofcDNA
Standard mutation nomenclature is used, but, for























Figure 3 Genotype determination for one of the infantile
(R208C) and one of the juvenile (R59OH) mutations by allele-specific
oligonucleotide hybridization (dot blot). Patients are numbered ac-
cording to table 1. N = normal probe; M = mutant probe. Infantile
cases 4 and 7 are homozygous for the R208C (or S) mutation. Juvenile




























Figure 4 Expression of mutant P-galactosidase in Cos-1 cells.
The mutant cDNAs gave catalytic activity toward 4-methylumbelli-
feryl 3-D-galactoside comparable to the intrinsic activity of Cos-1
cells as represented by the mock-transfected cells. The first bar (nor-
mal) depicts activities of Cos-1 cells transfected with normal P-galac-
tosidase cDNA. R208C (or S) = Arg208[CGC]-sCys[TGCJ; K577R (or
W) = Lys5'[AAGJ-*Arg[AGG]; R59OH (or U) = Arg¶[CGCJ-s
His[CAC]; E632G (or Z) = Glu632[GAA]-*-Gly[GGA].
nese mutations, letters are also assigned. Amplified seg-
ments covering the coding sequence were obtained
from fibroblasts from all patients. Sequence analysis of
the entire coding region revealed four single-base sub-
stitutions in the eight patients studied (fig. 2). The most
common mutation found was R208C (or S), initially
seen in infantile cases 1, 2, 4, and 7. A C--*T transition
at nucleotide (nt) 622 results in an amino acid change of
Arg to Cys at codon 208 in exon 6. A second mutation
seen in two infantile cases was K577R (or W), which is a
mutation occurring at the next-to-last base at the 3' end
of exon 15. An A-GG transition at nt 1733 results in a
Lys to Arg substitution at codon 577 in exon 15 (fig.
2a). In each of the juvenile cases a different mutation
was found, both in exon 16. The first mutation, R590H
(or U), was a G-IA substitution at nt 1769 resulting in
an Arg being replaced by a His at codon 590; the sec-
ond mutation, E632G (or Z), was an A--G transition at
nt 1915 resulting in a Glu to Gly change at codon 632
(fig. 2b). In each case multiple mutations were initially




Human Acid P-Galactosidase Mutations
MUTANT ALLELE
Author and Nomenclature Type Origin MUTATION
Yoshida et al. (1991):
IST (A) ................... Adult Japanese Iles--BThr
R201C (B) ................. Juvenile Japanese Arg20'--Cys
R457G (C) ................ Adult Japanese Arg4e57 Gln
(D) ................ Infantile Japanese Duplication
(nt 1069-1233)
All L1OP (E) ................. Polymorphism All ethnic groups Leu'0-*)Pro
Oshima et al. (1992):
W237L (F) ................ Morquio B American Trp237-Leu
R482H (G) ................ Morquio B American Arg482-8His
W509C (H) ................ Morquio B American Trp509-HCys
Yoshida et al. (1991):
G123R (I) ................. Infantile Japanese Gly123-*Arg
Y316C U) ................. Infantile Japanese Tyr3l6_aCys
G494C (K) ................. Infantile Japanese Gly494-Cys
(L) ................. Infantile Japanese Duplication
(nt 254-276)
Nishimito et al. (1991):
R49C (P) .................. Infantile Japanese Arg49-*Cys
R4571er (Q) ............... Infantile Japanese Arg4e7--Ter
Boustany et al. (present study):
R208C (S) ................. Infantile Hispanic Arg208'-*Cys
R590H (U) ................ Juvenile English Arg"--*His
K577R (W) ................ Infantile English LysS77-*Arg
E632G (Z) ................. Juvenile English-Scottish Glu632 -Gly
Chakraborty et al. (1991):
T80M (V) ................. Adult Danish-Danish Thr80-*.Met
clones (4-6), however, revealed only one of the muta-
tions to be real. Similarly to Nishimoto et al. (1991),
some of our patients had a Pro in codon 10 [CCT],
while others had a Leu [CTT]. For further verification,
mutation-bearing exons were amplified from genomic
DNA by PCR and were directly sequenced without
cloning into vectors.
Genotype Determination
Amplified genomic DNA was examined for determi-
nation of the genotype by means of allele-specific hy-
bridization, using the dot blot method (fig. 3). R208C
5' 3'
MUTATIONS E PAL B I S F J D QC QCH W U Zr'I' 1*11 II II,, I ,
EXONS 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
Figure 5 Acid 0-galactosidase cDNA. Note two clusterings
of mutations at the 5' end (exons 2 and 3) and 3' end (exons 14 and
15). Arrows indicate duplications.
accounted for one of the alleles in all cases. Also, two of
the infantile cases were homozygous for this mutation
(see table 1). Twelve normal and disease controls were
tested for the presence of the R208C mutation. Ten
cases were homozygous for the normal allele. Two of
the controls of Hispanic descent were heterozygous for
the R208C allele and had fibroblast P-galactosidase lev-
els that were 43.3% and 55.0% of normal (i.e., 44,078
and 56,053 nmol/mg protein/h, respectively, with a
mean for normal controls of 101,904 + 22,770). It was
impossible to test for the K577R mutation at the donor
end of exon 15, as insufficient intron 15 sequence data
were available to construct amplifying primers (Nanba
and Suzuki 1990, 1991). However, it was found as the
only mutation in the entire coding sequence in two
unrelated cases. We, therefore, presume it to be real.
Expression Studies in Cos- I Cells
Cos-1 cells transfected by the pSVL vector carrying
acid 03-galactosidase cDNA constructs of the four dif-
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ferent mutations failed to express fP-galactosidase activ-
ity over the intrinsic activity. Cos-1 cells transfected
with normal P-galactosidase cDNA had 2.5 times the
intrinsic activity level (fig. 4). There were no differences
observed among the different mutations in multiple in-
dependent experiments.
Discussion
These studies identify four new mutations in the acid
P-galactosidase gene that were different from the Japa-
nese GM1-gangliosidosis mutations and from those
causing Morquio B (see table 2). Each mutation results
in abolishment of the catalytic activity of the enzyme
protein as seen in the transient Cos-1 cell expression
experiments. Also, all sequenced abnormal alleles con-
tained only one mutation, with the rest of the coding
sequence being normal. Hence, each one of the four
new mutations described causes GM1-gangliosidosis.
The R208C (S) mutation in exon 6 accounts for 10 of
16 possible alleles. Two infantile cases from Puerto
Rico are homozygous for this mutation. The K577R
(W) mutation at the next-to-last base of exon 15 ac-
counts for two infantile alleles. Each of R590H (U) or
E632G (Z) accounts for the juvenile defining mutation
in one of the two juvenile cases. The other allele in both
juvenile cases was the infantile R208C allele. But, as
noted previously by others (Nishimoto et al. 1991), the
mutant enzyme with the higher residual activity will
determine clinical phenotype. Although our sample size
is limited, none of the juvenile defining alleles (R590H
or E632G) was seen in the infantile cases. Two alleles
remain unidentified.
Although the R208C mutation was the most com-
mon infantile mutation, the presence of at least two
others (K577R and unidentified) suggests that muta-
tions underlying infantile GM1-gangliosidosis in North
America and South America are heterogeneous. The
common occurrence of the R208C mutation in all cases
prompted us to investigate the possibility that it is a
commonly occurring mutation in North American and
South American populations. Ten normal controls of
pure Northern German (5), Swedish-German (1), En-
glish-English (3), and English-Scottish (1) descent did
not carry the R208C mutation. However, two of our
normal controls of Hispanic descent had one allele that
expressed the R208C mutation. Those two normal
controls had fibroblast 0-galactosidase activities in the
carrier range. Also, the fact that two GM1-gangliosido-
sis cases homozygous for the R208C mutation are of
Puerto Rican-Spanish extraction suggests this allele
may have spread to North America and South America
via Puerto Rico. A larger number of individuals need to
be studied before this can be confirmed.
The R208C mutation cannot be a polymorphism, as
it abolishes catalytic activity of the mutant protein in
Cos-1 cells and was the only identified mutation in the
patient-derived full f3-galactosidase cDNA. The most
compelling reason is that patients who carry this muta-
tion have GM1-gangliosidosis. Little is known about
structure/function relationships of human acid f3-ga-
lactosidase. However, two clusterings of all described
mutations occurring in exons 2 and 3 on the one hand
and exons 14 and 15 on the other hand (fig. 5) suggest
that these two areas could have important catalytic
and/or regulatory functions.
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